Viking Therapeutics (VKTX) Current Leases (2019 - 2025)
Viking Therapeutics (VKTX) reported Current Leases of $137000.0 for Q4 2025, down 71.98% on a YoY basis from $489000.0 in Q4 2024, and down 68.65% sequentially from $437000.0 in Q3 2025.
Viking Therapeutics (VKTX) Current Leases (2019 - 2025) Analysis & Trends
Viking Therapeutics (VKTX) has 7 years of Current Leases data on file, last reported at $137000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Leases fell 71.98% year-over-year to $137000.0; the trailing twelve-month figure through Dec 2025 stood at $137000.0 (down 71.98% YoY), and the FY2025 full-year result was $137000.0, down 71.98% from the prior year.
- Current Leases eased to $137000.0 in Q4 2025, from $437000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $498000.0 in Q1 2025 to a low of $29000.0 in Q4 2021.
- A 5-year average of $302500.0 and a median of $311500.0 in 2023 frame the typical range for Current Leases.
- Across the five-year window, Current Leases plunged 91.21% in 2021 and jumped 948.28% in 2022, its largest moves.
- Tracing VKTX's Current Leases over 5 years: stood at $29000.0 in 2021, then jumped by 948.28% to $304000.0 in 2022, then climbed by 6.58% to $324000.0 in 2023, then jumped by 50.93% to $489000.0 in 2024, then sank by 71.98% to $137000.0 in 2025.
- Business Quant data shows VKTX's Current Leases at $137000.0 in Q4 2025, $437000.0 in Q3 2025, and $468000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Viking Therapeutics | 4.09 Bn | 4.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | 437,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Mar 31, 2025 | 498,000.00 |
| Dec 31, 2024 | 489,000.00 |
| Sep 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 334,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 324,000.00 |
| Sep 30, 2023 | 319,000.00 |
| Jun 30, 2023 | 314,000.00 |
| Mar 31, 2023 | 309,000.00 |
| Dec 31, 2022 | 304,000.00 |
| Sep 30, 2022 | 299,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Mar 31, 2022 | 150,000.00 |
| Dec 31, 2021 | 29,000.00 |
| Sep 30, 2021 | 115,000.00 |
| Jun 30, 2021 | 198,000.00 |
| Mar 31, 2021 | 279,000.00 |